Antiviral therapy
Total Trials
6
As Lead Sponsor
As Collaborator
0
Total Enrollment
357
NCT03202992
Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) Infection
Phase: Phase 1
Role: Lead Sponsor
Start: Aug 11, 2017
Completion: Feb 4, 2019
NCT03239223
Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection
Start: Jan 1, 2018
Completion: Oct 30, 2018
NCT03677960
Start: Dec 17, 2018
Completion: Jun 30, 2019
NCT03697226
Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection.
Start: Dec 21, 2018
Completion: Jun 12, 2020
NCT05502367
A Study of ABI-2280 Vaginal Insert (Previously Referred to as ABI-2280 Vaginal Tablet) in Participants With Cervical Intraepithelial Neoplasia
Phase: Phase 1/2
Start: Sep 10, 2022
Completion: Jun 30, 2025
NCT06491446
Evaluating Clearance of High-Risk HPV and Safety After Administration of ABI-2280 Vaginal Inserts
Start: Mar 27, 2024
Completion: Feb 28, 2026
Loading map...